Thomas A. Dix
Corporate Officer/Principal bij Medical University of South Carolina
Profiel
Thomas A.
Dix is a Director and Chief Scientific Officer of Argolyn Bioscience, Inc. He is an Associate Professor of Pharmaceutical Sciences in the College of Pharmacy at the Medical University of South Carolina.
Previously, he was an Assistant Professor in the Departments of Chemistry and Biological Chemistry at the University of California, Irvine.
Dr. Dix received a PhD in Chemistry from Wayne State University.
Actieve functies van Thomas A. Dix
| Bedrijven | Functie | Begin |
|---|---|---|
| Medical University of South Carolina | Corporate Officer/Principal | 27-05-2009 |
Eerdere bekende functies van Thomas A. Dix
| Bedrijven | Functie | Einde |
|---|---|---|
Argolyn Bioscience, Inc.
 Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | Founder | 26-11-2009 |
| University of California, Irvine | Corporate Officer/Principal | - |
Opleiding van Thomas A. Dix
| Wayne State University (Michigan) | Doctorate Degree |
| The Pennsylvania State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | Health Technology |
